DUBLIN, Ireland & TAMPERE, Finland--(BUSINESS WIRE)--ERS Genomics Limited (‘ERS’), the CRISPR licensing Company, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results